Contribute
| Our Voice And Yours |
Lokvani Team
02/27/2026
Lokvani wishes all its readers a very Happy Holi Festival! ------------------------------------------------------------------------ Among the 2 Indian Americans Women of the year, Reshma Kewalramani was honored for her leadership in biomedical innovation as CEO of Vertex Pharmaceuticals, one of the largest biotechnology companies globally. She became the first woman to lead a large publicly traded U.S. biotech firm when she took over as CEO in 2020. Under her tenure, Vertex in late 2023 launched the first CRISPR-based gene-editing therapy for sickle cell disease and beta thalassemia. In January 2025, the company introduced a new class of FDA-approved nonopioid pain medication, the first such approval in more than two decades. Vertex has also continued to expand treatments for cystic fibrosis, with models suggesting that patients who begin therapy early could now live beyond the age of 70. TIME also highlighted Vertex’s pilot donation program, which has provided cystic fibrosis medicines free of charge to hundreds of patients in 14 countries, including India and El Salvador. Kewalramani told TIME that balancing the cost of drug development with access remains a central challenge for the industry. Sangeeta Bhatia, for pioneering the integration of microchip technology with biology, improving how drugs are tested and diseases are modeled, a fusion of engineering and lifesaving biology, and Aman Narang, for transforming digital restaurant operations, were 2 of the 11 Indian Americans recently named among 250 America’s Greatest Innovators by Forbes as part of the United States’ 250th anniversary celebrations.
https://www.newindiaabroad.com/english/people/time-names-2-indian-americans-women-of-the-year?utm_medium=email&utm_source=ctct
|
You may also access this article through our web-site http://www.lokvani.com/
